FindTrial
Sign In

Transurethral Resection versus Holmium Laser Enucleation of the Prostate: A Prospective Randomized Trial Comparing Perioperative Thrombin Generation and Fibrinolysis

Transurethral Resection versus Holmium Laser Enucleation of the Prostate: A Prospective Randomized Trial Comparing Perioperative Thrombin Generation and Fibrinolysis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800019005
Enrollment
Unknown
Registered
2018-10-21
Start date
2018-11-30
Completion date
Unknown
Last updated
2018-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

benign prostatic hyperplasia

Interventions

Group 1:Holmium Laser
Group 2:transurethral resection

Sponsors

the second affiliated hospital of zhejiang university school of medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: severe lower urinary tract symptoms (LUTS), refractory to medical therapy with alpha-blockers and/or 5-alpha reductase inhibitors, post void residual urine(PVR)>100ml, acute urinary retention.

Exclusion criteria

Exclusion criteria: neurogenic bladder, cardiovascular and/or cerebrovascular thromboembolic diseases, DVT, PE, malignancy, coagulopathy and on antiplatelet or anticoagulant therapy.

Design outcomes

Primary

MeasureTime frame
PF1+2;TAT;PAI-1;t-PA;—

Countries

China

Contacts

Public ContactFuding Bai

The Second Affiliated Hospital of Zhejiang University School of Medicine

bfd0816@hotmail.com+86 13757118232

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026